To test whether SFR1 is involved in transcriptional activation of native ERα target genes, we employed chromatin immunoprecipitation (ChIP) assays to look for ERα-dependent recruitment of SFR1 to the ERα binding sites on pS2 and PR promoters in MCF7 breast cancer cells. Here, SFR1 is linked to breast carcinoma.